Rule Change Tracker
Use this resource to follow changes to the NCMB’s administrative rules. The table below displays proposed rules and proposed amendments to existing rules.
Rules typically go through numerous revisions before they are finally approved by the NC Rules Review Commission (RRC). The NCMB will periodically update the text posted to reflect revisions. The final text of the rule will be posted pending approval by RRC.
REVIEW/APPROVAL PROCESS:
- The first step in the rules process is publication of the text of the proposed rule in the NC Register (Status = Published)
- The next step is a public hearing to receive written or oral comments on the proposed rule (Status = Public Hearing)
- Once comments are received and reviewed, the NCMB may make revisions to the rule based on feedback. The rule is then submitted to the NC Rules Review Commission for final approval (Status = Submitted to RRC)
- If the rule is approved by RRC, the status will be updated to indicate “Approved.”
COMMENTS: If you would like to comment on any of the proposed rules or amendments, you may send written comments via regular mail to Rules Coordinator, NC Medical Board, PO Box 20007, Raleigh, NC 27619 or you may .(JavaScript must be enabled to view this email address) your comments.
NOTE:Due to the ongoing COVID-19 pandemic, public hearings will be held virtually unless otherwise stated. Find call in information for each rule in the “EXPLANATION AND REASON” column for that rule.
| Rule | Name | Status | Explanation and Reason |
|---|---|---|---|
| 21 NCAC 32U .0101 | ADMINISTRATION OF VACCINES BY PHARMACISTS | Public Hearing 4/28/2210:00 AM |
Session Law 2021-110 required the Board of Pharmacy and the Medical Board to adopt “a statement of ethics for immunizing pharmacists.” Moreover, Session Law 2021-110 adopted “unprofessional conduct” as a new ground of discipline for pharmacists (and, by extension, pharmacies) in G.S. 90-85.38. The Boards have jointly proposed adoption of the American The Medical Board has proposed amending 21 NCAC 32U .0101 to effectively adopt the amendments to Rule .2507 by reference (and also thereby the application of new Rule .1820 to immunization). Public Hearing will be held via teleconference. The public may participate on MS Teams at https://tinyurl.com/2p8czkmb or may call 336-604-5350; conference ID 232 964 29# |
| 21 NCAC 32U .0102 | ADMINISRATION OF LONE-ACTING INJECTABLES | Public Hearing 4/28/2210:00 AM |
Session Law 2021-3, Section 2.9.(a), permits “immunizing pharmacists” (as defined by statute) to administer long-acting injectable medications to adults pursuant to prescription. The law became effective on October 1, 2021, and the Board of Pharmacy adopted a temporary rule (21 NCAC 46 .2514) to implement the section, as permitted by the statute. Because of the placement of the longacting injectable authority in the “immunizing pharmacist” statute (90-85.15B), a permanent rule governing the administration of these drugs must be approved by both the Board of Pharmacy and the Medical Board. The Board of Pharmacy has proposed adoption of a permanent version of Rule .2514. The proposed rule would put appropriate standards in place for training, recordkeeping and other requirements needed to ensure that the drugs are administered with adequate protection of the public health, safety, and welfare. The requirements in the proposed rule are largely imported from 21 NCAC 46 .2507, which governs immunizing pharmacist administration of vaccines, so that the regulated pharmacists will already be familiar with these requirements. Moreover, the proposed permanent rule does not vary in any substantial way from the temporary rule that has been operating without any known incident since October 1, 2021. The Medical Board has proposed a new rule (21 NCAC 32U .0102) that would adopt proposed permanent Rule .2514 by reference.
Public Hearing will be held via teleconference. The public may participate on MS Teams at https://tinyurl.com/2p8czkmb or may call 336-604-5350; conference ID 232 964 29# |
| 21 NCAC 32A .0112 | DISPOSITION OF REQUEST | Public Hearing 5/2/2210:00 AM |
To promote judicial economy by providing that the Board will decline to issue declaratory rulings for matters that are currently under investigation or are the subject of public disciplinary charges. The proposed amendments reflect the exhaustion of administrative remedies doctrine.
Public Hearing will be held via teleconference: 1-919-518-9840; Conference ID: 232 308 023# |
| 21 NCAC 32B .1303 | APPLICATION FOR PHYSICIAN LICENSE | Public Hearing 3/3/2210:00 AM |
To eliminate all USMLE Step 2 CS & COMLEX Level 2 PE licensure requirements related to all licensure applications. Public Hearing will be held via teleconference: 1-919-518-9840; |
| 21 NCAC 32B .1350 | REINSTATEMENT OF PHYSICIAN LICENSE | Public Hearing 3/3/2210:00 AM |
To eliminate all USMLE Step 2 CS & COMLEX Level 2 PE licensure requirements related to all licensure applications. Public Hearing will be held via teleconference: 1-919-518-9840; |
| 21 NCAC 32B .1402 | APPLICATION FOR RESIDENT'S TRAINING LICENSE | Public Hearing 3/3/2210:00 AM |
To eliminate all USMLE Step 2 CS & COMLEX Level 2 PE licensure requirements related to all licensure applications. Public Hearing will be held via teleconference: 1-919-518-9840; |
| 21 NCAC 32S .0213 | PHYSICIAN SUPERVISION OF PHYSICIAN ASSISTANTS | Public Hearing 3/3/2210:00 AM |
To clarify supervisory exemptions if multiple supervising physicians are involved in postgraduate training. Public Hearing will be held via teleconference: 1-919-518-9840; |
| 21 NCAC 32R .0102 | APPROVED CATEGORIES OF CME | Approved |
The proposed rule amendments are to raise licensee awareness of implicit bias and its negative impact on patient care. Effective: 12/15/2021 |
| 21 NCAC 32S .0216 | CONTINUING MEDICAL EDUCATION | Approved |
The proposed rule amendments are to raise licensee awareness of implicit bias and its negative impact on patient care. Effective: 12/15/2021 |